Pharmaq Analytiq has built a predictive health monitoring program for coho salmon that identifies disease risk before clinical signs emerge, combining molecular diagnostics, haematology, clinical pathology and histology into a single surveillance system.
The program operates as a “health traffic light,” flagging subclinical states and guiding production decisions at the freshwater stage. Results feed into the iWise® visualisation platform, which the company describes as unique to salmonid diagnostic units.
“More than discovering an isolated indicator, the advance has been in interpreting integrated and dynamic patterns,” said Jorge Infante, Diagnostics Services Manager at Pharmaq Analytiq. The system transforms variations previously considered normal into early risk signals.
Infante added that the model is built to each client’s production system but rests on standardised, time-comparable indicators, enabling it to scale across producers.
The program has been tested in the freshwater coho cycle at Salmones Camanchaca. The trigger was not a classic mortality event but a recurring condition in freshwater coho: icteric syndrome and its subclinical precursors.
Pharmaq Analytiq says the model is transferable to other coho producers and adaptable to Atlantic salmon and rainbow trout.